Notícias Regencell Bioscience Holdings Ltd - RGC | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Regencell Bioscience Holdings Ltd (RGC)
Regencell Bioscience Holdings Ltd (RGC) Notícias

Regencell Bioscience Holdings Ltd (RGC)

4,7785

0,0557

( 1,18% )

Atualizado: 15:08:28

Atrasado por 15 minutos

Discussões em tempo real e ideias de negociação: Negocie com confiança com nossa poderosa plataforma.

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO

Amended Statement of Beneficial Ownership (sc 13d/a)

Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Amended Statement of Beneficial Ownership (sc 13d/a)

Amended Statement of Beneficial Ownership (sc 13d/a)

Statement of Ownership (sc 13g)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Annual and Transition Report (foreign Private Issuer) (20-f)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

1
2
Próxima

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Regencell Bioscience

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições